Literature DB >> 26009603

Glucocorticoid-induced myopathy in the intensive care unit.

Heidi Shil Eddelien1, Henrik Westy Hoffmeyer2, Eva Løbner Lund3, Anne Øberg Lauritsen1.   

Abstract

Glucocorticoids (GC) are used for intensive care unit (ICU) patients on several indications. We present a patient who was admitted to the ICU due to severe respiratory failure caused by bronchospasm requiring mechanical ventilation and treated with methylprednisolone 240 mg/day in addition to antibiotics and bronchiolytics. When the sedation was lifted on day 10, the patient was awake but quadriplegic. Blood samples revealed elevated muscle enzymes, electromyography showed myopathy, and a muscle biopsy was performed. Glucocorticoid-induced myopathy was suspected, GC treatment was tapered, and muscle strength gradually returned. The patient made full recovery from the quadriplegia a few months later. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26009603      PMCID: PMC4458626          DOI: 10.1136/bcr-2015-209793

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Glucocorticoid-induced myopathy.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho
Journal:  Joint Bone Spine       Date:  2010-05-14       Impact factor: 4.929

Review 2.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

3.  Paresis acquired in the intensive care unit: a prospective multicenter study.

Authors:  Bernard De Jonghe; Tarek Sharshar; Jean-Pascal Lefaucheur; François-Jérome Authier; Isabelle Durand-Zaleski; Mohamed Boussarsar; Charles Cerf; Estelle Renaud; Francine Mesrati; Jean Carlet; Jean-Claude Raphaël; Hervé Outin; Sylvie Bastuji-Garin
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

Review 4.  Critical illness myopathy: what is happening?

Authors:  Oliver Friedrich
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-07       Impact factor: 4.294

5.  Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease.

Authors:  Rosario Amaya-Villar; Jose Garnacho-Montero; Jose Luis García-Garmendía; Juan Madrazo-Osuna; M Carmen Garnacho-Montero; Rafael Luque; Carlos Ortiz-Leyba
Journal:  Intensive Care Med       Date:  2004-12-04       Impact factor: 17.440

6.  Understanding critical illness myopathy: approaching the pathomechanism.

Authors:  Oliver Friedrich; Rainer H A Fink; Ernst Hund
Journal:  J Nutr       Date:  2005-07       Impact factor: 4.798

Review 7.  Treatment of critical illness polyneuropathy and/or myopathy - a systematic review.

Authors:  Mogens Ydemann; Heidi Shil Eddelien; Anne Øberg Lauritsen
Journal:  Dan Med J       Date:  2012-10       Impact factor: 1.240

Review 8.  A syndrome of acute severe muscle necrosis in intensive care unit patients.

Authors:  D A Ramsay; D W Zochodne; D M Robertson; S Nag; S K Ludwin
Journal:  J Neuropathol Exp Neurol       Date:  1993-07       Impact factor: 3.685

Review 9.  Critical illness myopathy.

Authors:  Nicola Latronico; Giuliano Tomelleri; Massimiliano Filosto
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

10.  Steroid-induced myopathy in the ICU.

Authors:  Bryan W Polsonetti; Saju D Joy; Luis F Laos
Journal:  Ann Pharmacother       Date:  2002-11       Impact factor: 3.154

View more
  2 in total

1.  Dimethyl fumarate ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis through enhancing Nrf2 signaling.

Authors:  Huayu Li; Mengyan Li; Chao Dong; Bing Liu
Journal:  Toxicol Res (Camb)       Date:  2022-05-14       Impact factor: 2.680

Review 2.  Corticosteroids in Acute Lung Injury: The Dilemma Continues.

Authors:  Daniela Mokra; Pavol Mikolka; Petra Kosutova; Juraj Mokry
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.